Pathology | Modality | Sensitivity | Specificity | PPV | NPV | Accuracy |
---|---|---|---|---|---|---|
Hodgkin’s lymphoma | PET/CT (95%CI) | 86 (76–96) | 90 (81–99) | 60 (46–74) | 97 (93–102) | 89 (81–98) |
BMB (95%CI) | 71 (59–84) | 48 (33–62) | 19 (8–30) | 90 (82–99) | 51 (37–65) | |
Non-Hodgkin’s lymphoma | PET/CT (95%CI) | 75 (56–94) | 73 (53–93) | 67 (45–88) | 80 (62–98) | 74 (54–93) |
BMB (95%CI) | 88 (73–102) | 73 (53–93) | 70 (49–91) | 89 (75–103) | 79 (61–97) | |
Total | PET/CT (95%CI) | 80 (70–90) | 86 (78–95) | 63 (52–75) | 94 (88–100) | 85 (76–93) |
BMB (95%CI) | 80 (70–90) | 53 (41–65) | 33 (22–45) | 90 (83–97) | 59 (47–71) |